Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bupivacaine hydrochloride and fentanyl citrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bufyl 1mg/ml and 2micrograms/ml 250ml infusion bags
1502010Z0BBAAAB
|
Bufyl | Bupivacaine hydrochloride and fentanyl citrate | Anaesthesia | No data available |
|
Bufyl 1mg/ml and 2micrograms/ml 500ml infusion bags
1502010Z0BBABAC
|
Bufyl | Bupivacaine hydrochloride and fentanyl citrate | Anaesthesia | No data available |
|
Bupivacaine 100mg (0.1%) / Fentanyl 200microg/100ml inf bags
1502010Z0AAAAAA
|
Bupivac hydrochloride and fentanyl citrate | Bupivacaine hydrochloride and fentanyl citrate | Anaesthesia | No data available |
|
Bupivacaine 250mg (0.1%) / Fentanyl 500microg/250ml inf bags
1502010Z0AAABAB
|
Bupivac hydrochloride and fentanyl citrate | Bupivacaine hydrochloride and fentanyl citrate | Anaesthesia | No data available |
|
Bupivacaine 500mg/500ml (0.1%) / Fentanyl 1mg/500ml inf bags
1502010Z0AAACAC
|
Bupivac hydrochloride and fentanyl citrate | Bupivacaine hydrochloride and fentanyl citrate | Anaesthesia | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.